The relation of serum monocyte chemoattractant protein-1 level with coronary atherosclerotic burden and collateral degree in stable coronary artery disease;Serum monosit kemoatraktan protein-1 düzeyinin kararli koroner arter hastaliǧinda koroner aterosklerotik yük ve kolateral derecesi ile ilişkisi

Turk Kardiyoloji Dernegi Arsivi

Volumn 39, Issue 4, 2011, Pages 269-275

  Şahinarslan, Asife ^a   Kocaman, Sinan Altan ^a   Topal, Salih ^a   Erçin, Uǧur ^b   Bukan, Neslihan ^b   Timurkaynak, Timur ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Biyokimya Anabilim Dali   (Turkey)

Author keywords

Atherosclerosis; Biological markers; Chemokine CCL2; Collateral circulation; Coronary angiography; Coronary artery disease

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS;

BIOLOGICAL MARKERS; CHEMOKINE CCL2; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 79959996504     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: 10.5543/tkda.2011.01290     Document Type: Article

References (29)

1. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74. (Pubitemid 36019640)
2. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
3. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001;2:108-15. (Pubitemid 33707927)
4. Viedt C, Vogel J, Athanasiou T, Shen W, Orth SR, Kübler W, et al. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factorkappaB and activator protein-1. Arterioscler Thromb Vasc Biol 2002;22:914-20. (Pubitemid 34655217)
5. Rollins BJ, Pober JS. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. Am J Pathol 1991;138:1315-9.
6. Poon M, Hsu WC, Bogdanov VY, Taubman MB. Secretion of monocyte chemotactic activity by cultured rat aortic smooth muscle cells in response to PDGF is due predominantly to the induction of JE/MCP-1. Am J Pathol 1996; 149:307-17. (Pubitemid 26231001)
7. Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease. Circ Res 2004;95:858-66. (Pubitemid 39435000)
8. Nakashima Y, Fujii H, Sumiyoshi S, Wight TN, Sueishi K. Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol 2007;27:1159-65. (Pubitemid 46641972)
9. Fukuchi M, Watanabe J, Kumagai K, Baba S, Shinozaki T, Miura M, et al. Normal and oxidized low density lipoproteins accumulate deep in physiologically thickened intima of human coronary arteries. Lab Invest 2002;82:1437-47. (Pubitemid 35191547)
10. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998;394:894-7. (Pubitemid 28410911)
11. Ortlepp JR, Vesper K, Mevissen V, Schmitz F, Janssens U, Franke A, et al. Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65 years of age. J Mol Med 2003;81:363-7. (Pubitemid 36783240)
12. McDermott DH, Yang Q, Kathiresan S, Cupples LA, Massaro JM, Keaney JF Jr, et al. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein- 1 levels and myocardial infarction in the Framingham Heart Study. Circulation 2005;112:1113-20. (Pubitemid 41216117)
13. de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003;107:690-5.
14. Hoogeveen RC, Morrison A, Boerwinkle E, Miles JS, Rhodes CE, Sharrett AR, et al. Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study. Atherosclerosis 2005;183:301-7. (Pubitemid 41579281)
15. Mosedale DE, Smith DJ, Aitken S, Schofield PM, Clarke SC, McNab D, et al. Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction. Atherosclerosis 2005; 183:268-74. (Pubitemid 41579277)
16. Rothenbacher D, Müller-Scholze S, Herder C, Koenig W, Kolb H. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers. Arterioscler Thromb Vasc Biol 2006;26:194-9. (Pubitemid 43732249)
17. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606. (Pubitemid 13187192)
18. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation 1986;74:469-76. (Pubitemid 16050148)
19. Aukrust P, Berge RK, Ueland T, Aaser E, Damas JK, Wikeby L, et al. Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. J Am Coll Cardiol 2001;37:485-91.
20. Matsumori A, Furukawa Y, Hashimoto T, Yoshida A, Ono K, Shioi T, et al. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 1997;29:419-23. (Pubitemid 27129164)
21. Nishiyama K, Ogawa H, Yasue H, Soejima H, Misumi K, Takazoe K, et al. Simultaneous elevation of the levels of circulating monocyte chemoattractant protein-1 and tissue factor in acute coronary syndromes. Jpn Circ J 1998; 62:710-2.
22. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29:2909-45.
23. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28:1598-660.
24. Deo R, Khera A, McGuire DK, Murphy SA, Meo Neto Jde P, Morrow DA, et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 2004;44:1812-8. (Pubitemid 39424080)
25. Tang W, Pankow JS, Carr JJ, Tracy RP, Bielinski SJ, North KE, et al. Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: the NHLBI Family Heart Study. BMC Cardiovasc Disord 2007;7:30.
26. Chen J, Krumholz HM. How useful is computed tomography for screening for coronary artery disease? Screening for coronary artery disease with electron-beam computed tomography is not useful. Circulation 2006;113:125-46.
27. Imoto K, Hiro T, Fujii T, Murashige A, Fukumoto Y, Hashimoto G, et al. Longitudinal structural determinants of atherosclerotic plaque vulnerability: a computational analysis of stress distribution using vessel models and three-dimensional intravascular ultrasound imaging. J Am Coll Cardiol 2005;46:1507-15. (Pubitemid 41446187)
28. Becker CR, Knez A, Ohnesorge B, Schoepf UJ, Flohr T, Bruening R, et al. Visualization and quantification of coronary calcifications with electron beam and spiral computed tomography. Eur Radiol 2000;10:629-35. (Pubitemid 30202649)
29. Park HJ, Chang K, Park CS, Jang SW, Ihm SH, Kim PJ, et al. Coronary collaterals: the role of MCP-1 during the early phase of acute myocardial infarction. Int J Cardiol 2008;130:409-13.